Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
- Sep 28, 2025
- 30:40
- Full Episode
(0:00) Introducing Eli Lilly CEO Dave Ricks (1:43) How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China (7:08) GLP-1 pricing and capital allocation after a breakout pharma product (12:56) Why Biotech VC has plummeted, “patent hacking” in China (15:32) Dave’s health regimen: good sleep, movement, healthy diet, social relationships, reading (18:32) Unexpected impacts of GLP-1s, helping with addictions, potential mental health use cases (21:16) Thoughts on RFK Jr, Big Pharma’s influence on the media, how AI empowers patients (25:27) Impact of proposed NIH cuts, explaining the “PBM boogeyman”, next major pharma breakthrough
Thanks to our partners for making this happen!
Solana - Solana is the high performance network powering internet capital markets, payments, and crypto applications. Connect with investors, crypto founders, and entrepreneurs at Solana’s global flagship event during Abu Dhabi Finance Week & F1: https://solana.com/breakpoint
OKX - The new way to build your crypto portfolio and use it in daily life. We call it the new money app. https://www.okx.com/
Google Cloud - The next generation of unicorns is building on Google Cloud's industry-leading, fully integrated AI stack: infrastructure, platform, models, agents, and data. https://cloud.google.com/
IREN - IREN AI Cloud, powered by NVIDIA GPUs, provides the scale, performance, and reliability to accelerate your AI journey. https://iren.com/
Oracle - Step into the future of enterprise productivity at Oracle AI Experience Live. https://www.oracle.com/artificial-intelligence/data-ai-events/
Circle - The America-based company behind USDC — a fully-reserved, enterprise-grade stablecoin at the core of the emerging internet financial system. https://www.circle.com/
BVNK - Building stablecoin-powered financial infrastructure that helps businesses send, store, and spend value instantly, anywhere in the world. https://www.bvnk.com/
Polymarket: https://www.polymarket.com/
Athletic Brewing: https://www.athleticbrewing.com/
Follow the besties: https://x.com/chamath https://x.com/Jason https://x.com/DavidSacks https://x.com/friedberg
Follow on X: https://x.com/theallinpod
Follow on Instagram: https://www.instagram.com/theallinpod
Follow on TikTok: https://www.tiktok.com/@theallinpod
Follow on LinkedIn: https://www.linkedin.com/company/allinpod
Intro Music Credit: https://rb.gy/tppkzl https://x.com/yung_spielburg
Intro Video Credit: https://x.com/TheZachEffect
Referenced in the show:
Brief Summary
Eli Lilly CEO Dave Ricks discusses GLP-1 drugs, their impact on obesity, and the challenges of pricing and counterfeit medications.
Key points
- Eli Liy's Revolutionary Pill. Eli Liy introduces a pill that works as effectively as injected GLP-1 drugs.
- The Journey of GLP-1 Drugs. Dave Ricks discusses the long and challenging development of GLP-1 drugs since 2006.
- Massive Revenue Growth. Eli Liy's drug sales surpassed $8 billion in Q2, becoming the best-selling drug ever.
- Counterfeit Concerns. Eli Liy addresses the challenges posed by counterfeit GLP-1 drugs in the market.
- Future of Obesity Drugs. Eli Liy discusses the moral imperative to reduce drug prices for obesity treatment.
- Reforming Food Accessibility. A call to make quality food cheaper and more accessible for everyone.
Episode highlights
- The Journey of GLP-1 DrugsDave Ricks discusses the long and challenging development of GLP-1 drugs since 2006.“Drug development is hard and long and requires a fair amount of failure and discipline.”2:31Sep 28, 2025
- Massive Revenue GrowthEli Liy's drug sales surpassed $8 billion in Q2, becoming the best-selling drug ever.“We reported global sales which surpassed Kitruda to becoming the bestselling drug in the world.”3:14Sep 28, 2025
- Counterfeit ConcernsEli Liy addresses the challenges posed by counterfeit GLP-1 drugs in the market.“There is a very active gray market, particularly in China.”5:24Sep 28, 2025
- Future of Obesity DrugsEli Liy discusses the moral imperative to reduce drug prices for obesity treatment.“We're committed to bringing the pricing down.”7:58Sep 28, 2025
- Reforming Food AccessibilityA call to make quality food cheaper and more accessible for everyone.“We should reform that and find ways to make quality food cheaper.”21:13Sep 28, 2025
- Vaccine SkepticismConcerns arise about the skepticism surrounding vaccines and its implications.“I worry about some of the stuff going on with vaccines right now.”21:30Sep 28, 2025
- AI in HealthcareThe speaker supports using AI for research, seeing it as a beneficial tool.“I think it's a huge plus.”24:28Sep 28, 2025
- Brain Diseases DiscussionA deep dive into the challenges posed by brain diseases and mental health.“We could spend a whole panel talking about brain diseases.”29:31Sep 28, 2025





